What is DNA X, Inc. (SONM) stock price today?

DNA X, Inc. (SONM) is currently trading at $3.17, up 0.45% today.

What is SONM P/E ratio?

DNA X, Inc.'s P/E ratio is -0.14. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is SONM return on equity (ROE)?

DNA X, Inc.'s return on equity (ROE) is 668.17%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is DNA X, Inc.'s market cap?

DNA X, Inc. has a market capitalization of $4.71M.

NASDAQ · Communication Equipment

DNA X, Inc. (SONM) Stock

$3.17 +0.45% NASDAQ: SONM Technology

DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California.

Valuation

Metric	Value
Price	$3.17
Market Cap	$4.71M
P/E Ratio	-0.14
P/B Ratio	-48.02
P/S Ratio	-0.28
EPS (TTM)	$-1.59
52-Week High	$16.97
52-Week Low	$2.52
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	668.17%
ROA	-305.39%
ROCE	125.00%
Gross Margin	75.69%
Operating Margin	57.83%
Net Margin	88.36%
Debt/Equity	-12.92
Current Ratio	0.60

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$55.0M	$70.0M	$94.0M	$58.0M	$0
Operating Profit	$-38.0M	$-14.0M	$1.0M	$-34.0M	$-5.0M
Net Profit	$-39.0M	$-14.0M	$0	$-34.0M	$-21.0M
EPS	$-40.81	$-4.88	$-0.02	$-7.13	$-1.59
Op Margin	-69.6%	-20.5%	0.6%	-57.7%	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$41.0M	$54.0M	$56.0M	$40.0M	$44.0M
Total Liabilities	$22.0M	$34.0M	$34.0M	$45.0M	$51.0M
Cash	$11.0M	$13.0M	$9.0M	$5.0M	$1.0M
Borrowings	$0	$0	$0	$0	$5.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-38.0M	$-12.0M	$-4.0M	$-8.0M	$-24.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-11.0M	$2.0M	$-4.0M	$-4.0M	$-4.0M
Free Cash Flow	$-39.0M	$-12.0M	$-4.0M	$-9.0M	$-24.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.72
FCF Yield	-509.51%
Quick Ratio	0.60
Interest Coverage	-5.00
Return 1Y	-70.33%
Return 3Y	-98.18%
Return 5Y	-99.49%

Ownership

Insiders Held36.10%

Institutions Held7.44%

Institutions Float Held11.65%

Institutional Holder	Shares	Report Date
UBS Group AG	36,219	2026-03-31
C2c Wealth Management, LLC	35,500	2026-06-30
Geode Capital Management, LLC	14,802	2026-03-31
Blackrock Inc.	14,006	2026-03-31
Vanguard Capital Management LLC	4,892	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BHATFujian Blue Hat Interactive Entertainment Technology Ltd.	$0.68	+349.70%	0.00	$97793	0.00%
CLRO	$4.90	-8.24%	-0.49	$8.53M	0.00%
FIEE	$2.99	-1.64%	68.80	$11.10M	0.00%
GXAI	$0.82	-2.50%	-2.18	$6.15M	0.00%
MITQ	$0.52	+1.96%	-6.10	$5.17M	0.00%

About DNA X, Inc.

DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in delivering enterprise-grade 5G solutions across a broad international footprint, encompassing the United States, Canada, Europe, the Middle East, and the Asia-Pacific region. Their product portfolio includes a comprehensive range of ruggedized communication devices tailored for frontline and task workers. This lineup features models such as the Sonim XP10, Sonim XP5plus, Sonim XP3plus, Sonim XP Pro, as well as the XP100 4G and XP400 5G professional rugged phones, XP Pro 5G rugged smartphones, and XP3plus 5G rugged flip phones. Beyond handsets, DNA X, Inc. also provides connected solutions, offering both fixed wireless access and mobile hotspot devices. These include the Sonim H100 low- and mid-range mobile hotspots, the Sonim H700, and the advanced Sonim H500-series of 5G mobile hotspots. Complementing its hardware offerings, the company supplies proprietary SonimWare software and a selection of industrial-grade accessories. DNA X, Inc. distributes its products through a diverse network that includes wireless carriers, data device distributors, communications system integrators, and electronics resellers. The company's clientele spans various critical industries, including transportation and logistics, construction, manufacturing, facilities management, energy and utilities, mining, federal government agencies, and public safety organizations.

DNA X, Inc. is led by CEO Michael C. Mulica, employs 160 people, headquartered in US, publicly traded since 2019.

DNA X, Inc. (SONM) stock trades at $3.17 with a market capitalization of $4.71M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of -48.02, price-to-sales of -0.28. Over the past 52 weeks the stock has ranged between $2.52 and $16.97, and currently trades 81.3% below its 52-week high.

On profitability, DNA X, Inc. generates a return on equity (ROE) of 668.17% — well above the market average, a sign of a high-quality business, return on capital employed of 125.00%, an operating margin of 57.83%, a net profit margin of 88.36%.

Official website: ir.dna-x.global

Related Technology Stocks

NVDA Semiconductors $223.96 +2.27% AAPL Consumer Electronics $313.33 +0.29% MSFT Software - Infrastructure $499.99 +0.03% AVGO Semiconductors $427.76 +1.71% TSM Semiconductors $374.67 -4.50% MU Semiconductors $739.00 -9.94% AMD Semiconductors $483.36 -1.21% ASML Semiconductors $1550.69 -2.04% INTC Semiconductors $101.65 +1.84% CSCO Communication Equipment $120.59 -0.24% ORCL Software - Infrastructure $146.94 +2.42% AMAT Semiconductors $436.45 -8.40%

Screens featuring this stock

High ROE Technology Stocks Low P/E Technology Stocks High Net Margin Technology Stocks Dividend Technology Stocks Low Debt Technology Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides